WallStSmart
EVH

Evolent Health Inc

NYSE: EVH · HEALTHCARE · HEALTH INFORMATION SERVICES

$3.75
-1.06% today

Updated 2026-04-30

Market cap
$349.43M
P/E ratio
P/S ratio
0.19x
EPS (TTM)
$-5.07
Dividend yield
52W range
$2 – $12
Volume
3.2M

Evolent Health Inc (EVH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-60.8%
Last 4 quarters
Revenue YoY growth
-27.5%
Most recent quarter
EPS YoY growth
+500.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+29.7%
2026-02-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$0.08+51.2%$2.56$3.32+29.7%
2025-11-06$0.05-54.5%$6.35$4.96-21.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.05$0.08+51.2%$468.72M-27.5%
2025-09-30$0.11$0.05-54.5%$479.53M-22.8%
2025-06-30$0.08$-0.10-225.0%$444.33M-31.3%
2025-03-31$0.10$0.06-40.0%$483.65M-24.4%
2024-12-31$0.01$-0.02-260.0%$646.54M+16.3%
2024-09-30$0.34$0.04-88.2%$621.40M+21.6%
2024-06-30$0.25$0.30+20.0%$647.14M+37.9%
2024-03-31$0.24$0.34+41.7%$639.65M+49.6%
2023-12-31$0.15$0.23+53.3%$556.05M
2023-09-30$0.07$0.30+328.6%$511.01M
2023-06-30$0.11$0.14+27.3%$469.14M
2023-03-31$0.20$0.21+5.0%$427.69M

Frequently asked questions

Has Evolent Health Inc beaten earnings estimates?
Evolent Health Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -60.8% over the last 4 quarters.
How does EVH stock react to earnings?
EVH stock has moved an average of +3.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Evolent Health Inc's revenue growth rate?
Evolent Health Inc reported year-over-year revenue growth of -27.5% in its most recent quarter, with EPS growing +500.0% year-over-year.